PROGRAM


Use the use the filter options below, then click on a session title from the list below to view the agenda details. Please note this is not the final program. The agenda is subject to change.

No sessions found.

Coronary: Core

No Results Found

Wednesday, September 25, 2019

Oral Abstract Session

Intravascular Imaging

Physiologic Guidance: Hyperemic, Basal, and Angiographic Studies

Thursday, September 26, 2019

Main Arena

Main Arena I: Thursday, Sept. 26

Live Case Theater

Live Case Transmission Theater I: Thursday, Sept. 26

Live Case Transmission Theater II: Thursday, Sept. 26

Concurrent Session

Metallic DES Part 1: Stent Differences and DAPT Duration

PCI Pharmacotherapy: Part 1

Intravascular Imaging Stent Guidance: Part 1 — The Basics

Physiologic Lesion Assessment and Interventional Planning: Part 1 — Current Controversies in Coronary Physiology

International Complex Case Session

International Complex Case Session II: Featured Complex Coronary Cases

Evening Program

TWILIGHT at Twilight: Assessing the Role of Monotherapy vs. Dual Therapy ⁠— Examining Current Data (Sponsored by CRF; Supported by AstraZeneca)

Challenging Case

Challenging Cases 1

Challenging Cases 2

Poster Abstract Session

Poster Abstracts I

Moderated Poster

Intravascular Imaging - 1

Vascular Access and Closure in PCI - 1

Bioresorbable Scaffolds - 1

Drug-Eluting Stent Studies - 1

Imaging-Derived Physiologic Lesion Assessment - 1

Bioresorbable Scaffolds - 2

Physiologic Lesion Assessment - 1

Renal Insufficiency and Contrast Nephropathy - 1

Drug-Eluting Balloons and Local Drug Delivery - 1

Drug-Eluting Stent Studies - 2

Management of Antiplatelet Therapy and Anticoagulation in Patients Undergoing PCI - 1

Physiologic Lesion Assessment - 2

Renal Insufficiency and Contrast Nephropathy - 2

Drug-Eluting Balloons and Local Drug Delivery - 2

Intravascular Imaging - 2

Management of Antiplatelet Therapy and Anticoagulation in Patients Undergoing PCI - 2

Drug-Eluting Balloons and Local Drug Delivery - 3

PCI vs. Medical Therapy and Insights Into Trial Design

Vulnerable Plaques and High Risk Patients - 1

Friday, September 27, 2019

Main Arena

Main Arena II: Friday, Sept. 27

Live Case Theater

Live Case Transmission Theater IV: Friday, Sept. 27

Concurrent Session

Metallic DES Part 2: High-Risk Patients and Revascularization Failures

Intravascular Imaging Stent Guidance: Part 2 — The Details

PCI Pharmacotherapy: Part 2

Physiologic Lesion Assessment and Interventional Planning: Part 2 — New Developments in Coronary Physiology

Innovation Keynote Theater

High-Impact Clinical Research II: High-Risk Disease and Novel Therapies

High-Impact Clinical Research III: Pharmacotherapy Strategies and Calcified Lesions

Hot Topic Lunch

Cath Lab Radiation Management: In Remembrance of Charles Chambers

Clinical Trial Design, Statistics, and Literature Interpretation: The Evidence-Based Medicine Expert ⁠— Part 1

Detection and Treatment of Vulnerable Plaques and Vulnerable Patients: Are We There Yet?

Diabetic Debates: Revascularization and Medical Therapies

Transcatheter Cardiovascular Innovations in the Underserved: Current Challenges and Opportunities ⁠— Sponsored by the Association of Black Cardiologists

International Complex Case Session

International Complex Case Session IV: Coronary Thrombus Management and Other Special PCI Situations

International Complex Case Session V: Featured Complex Coronary Cases

International Complex Case Session VI: Featured Complex Coronary Cases

Evening Program

Expanding Applications for Intravenous Platelet Inhibition (Sponsored by CRF; Supported by Chiesi)

Challenging Case

Challenging Cases 3

Poster Abstract Session

Posters Abstracts II

Moderated Poster

Management of Antiplatelet Therapy and Anticoagulation in Patients Undergoing PCI - 3

Physiologic Lesion Assessment - 3

Bioresorbable Scaffolds - 3

Drug-Eluting Stent Studies - 3

Cath Lab of the Future - 1

Chronic Total Occlusions - 2

Vascular Access and Closure in PCI - 2

Bioresorbable Scaffolds - Metallic

Imaging-Derived Physiologic Lesion Assessment - 2

Atrial Fibrillation in Patients Undergoing Catheter-Based Intervention

Intravascular Imaging - 3

Resting Physiologic Indices

Cath Lab of the Future - 2

Saturday, September 28, 2019

Live Case Theater

Live Case Transmission Theater V: Saturday, Sept. 28

Live Case Transmission Theater VI: Saturday, Sept. 28

Concurrent Session

Coronary Drug-Coated Balloons and Bioresorbable Scaffolds

Radial and Femoral Access and Intervention

Innovation Keynote Theater

High-Impact Clinical Research IV: Adjunctive Pharmacotherapy Studies

High-Impact Clinical Research VII: PCI With Physiologic Guidance

High-Impact Clinical Research IX: CAD Diagnosis and Complex PCI Strategies

Hot Topic Lunch

Chronic Kidney Disease: Preventing and Treating Contrast Nephropathy

Clinical Trial Design, Statistics, and Literature Interpretation: The Evidence-Based Medicine Expert ⁠— Part 2

Spontaneous Coronary Artery Dissection: Novel Insights on Diagnosis and Treatment

International Complex Case Session

International Complex Case Session VIII: A Potpourri of Complex Interventional Cases I

International Complex Case Session IX: A Potpurri of Complex Interventional Cases II

Breakfast Program

Aspirin for the Interventionalist: More Than Meets the Eye (Sponsored by CRF; Supported by PLX Pharma)

Evening Program

DAPT and Triple Therapy: A Case-Based Guide to Optimal Antiplatelet Therapies (Sponsored by CRF; Supported by Abbott, Boston Scientific Corporation, and Medtronic)

Oral Abstract Session

Highest Graded Abstracts of TCT 2019

Challenging Case

Challenging Cases 5

Challenging Cases 6

Moderated Poster

Bioresorbable Scaffolds - 4

Drug-Eluting Stent Studies - 4

Intravascular Imaging - 4

Vulnerable Plaques and High-Risk Patients - 2

Drug-Eluting Stent Studies - Biodegradable Polymers

Management of Antiplatelet Therapy and Anticoagulation in Patients Undergoing PCI - 4

PCI and Bleeding Complications

Vascular Access and Closure in PCI - 3

Vulnerable Plaques and High Risk Patients - 3

Biomarkers and Outcomes

Cath Lab of the Future - 3

Coronary Artery Surgery

Vascular Access and Closure in PCI - 4

Sunday, September 29, 2019

Main Arena

Main Arena IV: Sunday, Sept. 29

Breakfast Program

Guidewire Design and Selection: A User’s Guide (Sponsored by CRF; Supported by Abbott and Boston Scientific Corporation)

Structural: Valve

No Results Found

Wednesday, September 25, 2019

Evening Program

Women in Structural Heart (WISH): Breaking the Glass Ceiling ⁠— An Evening of Complex Cases (Sponsored by CRF; Supported by Abbott, Boston Scientific Corporation, Edwards Lifesciences, and Medtronic)

Satellite Special Session

Collaborators in TAVR: A Medtronic Course in Collaboration With CRF for New-to-TAVR Heart Teams

Oral Abstract Session

Complications of TAVR and Other Large Devices

TAVR Complications and Congenital Heart Disease Interventions

Mitral and Tricuspid Valve Interventions

Novel TAVR Data

Thursday, September 26, 2019

Main Arena

Main Arena I: Thursday, Sept. 26

Live Case Theater

Live Case Transmission Theater I: Thursday, Sept. 26

Live Case Transmission Theater II: Thursday, Sept. 26

Concurrent Session

MitraClip Studies and Technique

TAVR Indications and Complications

International Complex Case Session

International Complex Case Session I: Featured Structural Heart Disease Cases

International Complex Case Session III: Featured Structural Heart Disease Cases

Challenging Case

Challenging Cases 2

Poster Abstract Session

Poster Abstracts I

Moderated Poster

Assessment of Patients With Aortic Stenosis or Aortic Insufficiency - 1

Natural History and Management of Mitral and Tricuspid Valve Disease - 1

Natural History and Management of Mitral and Tricuspid Valve Disease - 2

Pacemakers and Conduction Abnormalities in Patients With TAVR - 1

Natural History and Management of Mitral and Tricuspid Valve Disease - 3

Pacemakers and Conduction Abnormalities in Patients With TAVR - 2

TAVR and Coronary Artery Disease - 1

Pacemakers and Conduction Abnormalities in Patients With TAVR - 3

Assessment of Patients With Aortic Stenosis or Aortic Insufficiency - 2

Natural History and Management of Mitral and Tricuspid Valve Disease - 4

TAVR and Coronary Artery Disease - 2

Natural History and Management of Mitral and Tricuspid Valve Disease - 5

TAVR: Patient-Prosthesis Mismatch

TAVR: Valve-in-Valve - 1

Friday, September 27, 2019

Main Arena

Main Arena II: Friday, Sept. 27

Live Case Theater

Live Case Transmission Theater III: Friday, Sept. 27

Concurrent Session

TAVR Technology and Associated Devices

TAVR Special Situations (VIV, Bicuspid, AR, Low-Flow, Other)

Transcatheter Mitral Valve Repair: Beyond the MitraClip

Evening Program

China: Innovations in Structural Heart Disease (Organized by CRF; Sponsored by Venus Medtech)

Challenging Case

Challenging Cases 3

Challenging Cases 4

Poster Abstract Session

Posters Abstracts II

Moderated Poster

Natural History and Management of Bicuspid Aortic Valve Disease

Natural History and Management of Mitral and Tricuspid Valve Disease - 6

TAVR: Clinical Access and Cost-Effectiveness - 1

TAVR: Valve-in-Valve - 2

Assessment of Patients With Aortic Stenosis or Aortic Insufficiency - 3

TAVR: Clinical Access and Cost-Effectiveness - 2

TAVR vs. SAVR and TAVR vs. TAVR - 1

TAVR Comorbidities and Complications - 1

Vascular Access for TAVR - 1

Vascular Access for TAVR - 2

Saturday, September 28, 2019

Main Arena

Main Arena III: Saturday, Sept. 28

Live Case Theater

Live Case Transmission Theater VI: Saturday, Sept. 28

Concurrent Session

Tricuspid Regurgitation: Evolving Concepts and Technologies

Transcatheter Mitral Valve Replacement

Mitral Trial Design, Anticoagulation, Imaging, and More

Innovation Keynote Theater

High-Impact Clinical Research V: Transcatheter Aortic Valve Replacement

High-Impact Clinical Research VIII: Valve Therapies and Non-Cardiac Surgery

Hot Topic Lunch

Combined Structural Interventions: Two Valves, Valve and LAAO, and More

Breakfast Program

Percutaneous Mitral Interventions: Standard of Care and Future Development (Sponsored by CRF; Supported by Abbott)

Challenging Case

Challenging Cases 5

Challenging Cases 6

Moderated Poster

Novel Aortic Devices and Approaches

Detection and Closure of Paravalvular Leaks

TAVR Comorbidities and Complications - 2

TAVR vs. SAVR and TAVR vs. TAVR - 2

TAVR Comorbidities and Complications - 3

TAVR vs. SAVR and TAVR vs. TAVR - 3

TAVR Comorbidities and Complications - 4

TAVR Leaflet Thickening and Thrombosis

Vascular

No Results Found

Wednesday, September 25, 2019

TCT Endovascular

TCT Endovascular: An Alliance Partner With the VEITH Symposium

Oral Abstract Session

Endovascular Interventions

Hypertension and Heart Failure Therapies

Thursday, September 26, 2019

Concurrent Session

Large-Bore Access and Closure

Pulmonary Hypertension and Acute and Chronic Pulmonary Emboli Therapies: Part 1

Breakfast Program

Controversies in SFA Intervention (Sponsored by CRF; Supported by Medtronic and WL Gore & Associates)

Challenging Case

Challenging Cases 1

Poster Abstract Session

Poster Abstracts I

Moderated Poster

Stroke and Stroke Prevention

Large-Bore Vascular Access and Closure

Peripheral Vascular Intervention - 1

Pulmonary Artery and Pulmonary Venous Intervention

Friday, September 27, 2019

Main Arena

Main Arena II: Friday, Sept. 27

Live Case Theater

Live Case Transmission Theater III: Friday, Sept. 27

Concurrent Session

Pulmonary Hypertension and Acute and Chronic Pulmonary Emboli Therapies: Part 2

Innovation Keynote Theater

High-Impact Clinical Research I: Peripheral Arterial Disease and Drug-Coated Balloons

Hot Topic Lunch

TCT Endovascular: Treatment of Acute Pulmonary Embolism

TCT Endovascular and VEITH: Aortic Therapies

Challenging Case

Challenging Cases 3

Challenging Cases 4

Moderated Poster

Peripheral Vascular Intervention - 2

Peripheral Vascular Intervention - 3

Peripheral Vascular Intervention - 4

Saturday, September 28, 2019

Main Arena

Main Arena III: Saturday, Sept. 28

Live Case Theater

Live Case Transmission Theater VI: Saturday, Sept. 28

Concurrent Session

Hypertension Therapies: Renal Denervation and Beyond

Hot Topic Lunch

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Center Expertise and Illustrative Case Demonstrations

TCT Endovascular: Neuro Interventions for Stroke and Carotid Stenosis

Breakfast Program

Current Perspectives and Future Technologies in Below-the-Knee Intervention (Sponsored by CRF; Supported by Medtronic and WL Gore & Associates)

Challenging Case

Challenging Cases 5

Moderated Poster

Renal Denervation

Structural: Non-Valve

No Results Found

Wednesday, September 25, 2019

Oral Abstract Session

LAA Closure and Pulmonary Emboli Therapies

Thursday, September 26, 2019

Main Arena

Main Arena I: Thursday, Sept. 26

Live Case Theater

Live Case Transmission Theater II: Thursday, Sept. 26

Concurrent Session

Left Atrial Appendage Closure: Part 1 — LAA Closure: Current Status and Future Directions

International Complex Case Session

International Complex Case Session I: Featured Structural Heart Disease Cases

International Complex Case Session III: Featured Structural Heart Disease Cases

Challenging Case

Challenging Cases 1

Challenging Cases 2

Poster Abstract Session

Poster Abstracts I

Friday, September 27, 2019

Main Arena

Main Arena II: Friday, Sept. 27

Live Case Theater

Live Case Transmission Theater III: Friday, Sept. 27

Concurrent Session

PFO Closure: Evidence, Indications, and Devices

Left Atrial Appendage Closure: Part 2 — Unanswered Questions, Future Directions

Hot Topic Lunch

Techniques and Case Studies in PFO Closure

Evening Program

China: Innovations in Structural Heart Disease (Organized by CRF; Sponsored by Venus Medtech)

Challenging Case

Challenging Cases 4

Moderated Poster

Left Atrial Appendage Exclusion - 1

Left Atrial Appendage Exclusion - 2

Alcohol Septal Ablation/HOCM

Treatment of Congenital Heart Diseases - 1

Treatment of Congenital Heart Diseases - 2

Interventional Heart Failure

Saturday, September 28, 2019

Main Arena

Main Arena III: Saturday, Sept. 28

Concurrent Session

Interventional Heart Failure and Hemodynamic Support: Chronic Therapies

Hot Topic Lunch

Complex Adult Congenital Intervention

Hypertrophic Cardiomyopathy and Septal Ablation

Challenging Case

Challenging Cases 5

Challenging Cases 6

Coronary: CHIP

No Results Found

Wednesday, September 25, 2019

Oral Abstract Session

AMI and Vulnerable Plaque and Patient Studies

DES and Bioresorbable Scaffolds

PCI in Patients With Heavily Calcified Lesions and Chronic Kidney Disease

CTO Interventions

Complex PCI and Left Main Interventions

Thursday, September 26, 2019

Main Arena

Main Arena I: Thursday, Sept. 26

Live Case Theater

Live Case Transmission Theater I: Thursday, Sept. 26

Live Case Transmission Theater II: Thursday, Sept. 26

Concurrent Session

The Left Main and Bifurcation Summit: Part 1

STEMI, Cardiac Arrest, and Cardiogenic Shock: Part 1

International Complex Case Session

International Complex Case Session II: Featured Complex Coronary Cases

Challenging Case

Challenging Cases 1

Challenging Cases 2

Poster Abstract Session

Poster Abstracts I

Moderated Poster

Outcomes After Primary PCI - 1

Revascularization in Patients With Diabetes - 1

Revascularization in the Elderly and the Frail - 1

EXCEL Trial Clinical Substudies - 1

Outcomes After Primary PCI - 2

EXCEL Trial Clinical Substudies - 2

Outcomes After Primary PCI - 3

Revascularization in the Elderly and the Frail - 2

Outcomes after Primary PCI - 4

Stent Thrombosis and Restenosis - 1

Non-Atherosclerotic CAD (SCAD, MINOCA, etc.) - 1

Ventricular Assist and Management of Cardiogenic Shock - 1

Non-Atherosclerotic CAD (SCAD, MINOCA, etc.) - 2

Ventricular Assist and Management of Cardiogenic Shock - 2

Friday, September 27, 2019

Live Case Theater

Live Case Transmission Theater IV: Friday, Sept. 27

Concurrent Session

The Left Main and Bifurcation Summit: Part 2

STEMI, Cardiac Arrest, and Cardiogenic Shock: Part 2

Innovation Keynote Theater

High-Impact Clinical Research II: High-Risk Disease and Novel Therapies

High-Impact Clinical Research III: Pharmacotherapy Strategies and Calcified Lesions

International Complex Case Session

International Complex Case Session IV: Coronary Thrombus Management and Other Special PCI Situations

International Complex Case Session V: Featured Complex Coronary Cases

International Complex Case Session VI: Featured Complex Coronary Cases

Evening Program

CHIP Angiogram Review: What’s New? (With Focused Case Presentations) (Sponsored by CRF; Supported by Abbott, ABIOMED, Inc., Boston Scientific Corporation, and CSI)

Challenging Case

Challenging Cases 3

Challenging Cases 4

Poster Abstract Session

Posters Abstracts II

Moderated Poster

LMCA Intervention - 1

Outcomes After Primary PCI - 5

Revascularization in Patients With Diabetes - 2

Chronic Total Occlusions - 1

LMCA Intervention - 2

Outcomes After Primary PCI - 6

Rotational and Orbital Atherectomy, Cutting/Scoring Balloons, and Lithotripsy

Chronic Total Occlusions - 3

Coronary Bifurcation Intervention

SVG Intervention

Out-of-Hospital Arrest

Coronary Perforation and Cardiac Tamponade

Stent Thrombosis and Restenosis - 2

Ventricular Assist and Management of Cardiogenic Shock - 3

Saturday, September 28, 2019

Live Case Theater

Live Case Transmission Theater V: Saturday, Sept. 28

Live Case Transmission Theater VI: Saturday, Sept. 28

Concurrent Session

Treatment of Coronary Calcification

The CTO Summit: Part 1

The CTO Summit: Part 2

Innovation Keynote Theater

High-Impact Clinical Research VI: Management of Cardiogenic Shock

High-Impact Clinical Research IX: CAD Diagnosis and Complex PCI Strategies

International Complex Case Session

International Complex Case Session VII: Featured CHIP and Other Special PCI Situations

International Complex Case Session VIII: A Potpourri of Complex Interventional Cases I

International Complex Case Session IX: A Potpurri of Complex Interventional Cases II

Evening Program

DAPT and Triple Therapy: A Case-Based Guide to Optimal Antiplatelet Therapies (Sponsored by CRF; Supported by Abbott, Boston Scientific Corporation, and Medtronic)

Challenging Case

Challenging Cases 5

Challenging Cases 6

Moderated Poster

Hemodynamic Support During PCI

Age and Gender and Primary PCI

Mortality After PCI

Chronic Total Occlusions - 4

Sunday, September 29, 2019

Main Arena

Main Arena IV: Sunday, Sept. 29

Innovation

No Results Found

Wednesday, September 25, 2019

Innovation Keynote Theater

TCT Innovation I: Global Perspectives in MedTech and Emerging Technological Trends

TCT Innovation II: Emerging Technological Trends II

TCT Innovation II: Emerging Technological Trends II

Thursday, September 26, 2019

Innovation Keynote Theater

TCT Innovation III: TCT Shark Tank Innovation Competition

TCT Innovation IV: Global Perspectives in MedTech Innovation II and Digital Healthcare

FDA Town Hall

FDA Town Hall Meeting Part 1: Goals for 2019/2020

Friday, September 27, 2019

Main Arena

Main Arena II: Friday, Sept. 27

Innovation Keynote Theater

TCT Innovation V: Keynote Innovation Interventional Studies

FDA Town Hall

FDA Town Hall Meeting Part 2: Hot Topics

Saturday, September 28, 2019

Main Arena

Main Arena III: Saturday, Sept. 28

Innovation Keynote Theater

Fascinating Lectures

FDA Town Hall

FDA University at TCT

Breakfast Program

Current Perspectives and Future Technologies in Below-the-Knee Intervention (Sponsored by CRF; Supported by Medtronic and WL Gore & Associates)

Moderated Poster

Pre-Clinical Models and Studies

Nurse\Technologist Track

No Results Found

Wednesday, September 25, 2019

Nurse and Technologist Symposium

CardioVascular Professionals (CVP) Course: 28th Annual Cardiovascular Nurse and Technologist Symposium

Wednesday, September 25, 2019

Innovation Keynote Theater

TCT Innovation I: Global Perspectives in MedTech and Emerging Technological Trends

TCT Innovation II: Emerging Technological Trends II

TCT Innovation II: Emerging Technological Trends II

TCT Endovascular

TCT Endovascular: An Alliance Partner With the VEITH Symposium

Nurse and Technologist Symposium

CardioVascular Professionals (CVP) Course: 28th Annual Cardiovascular Nurse and Technologist Symposium

Special Session

ABCs of Interventional Cardiology

Regional Session

The Best of Intervention From Europe: Complex Coronary and Structural Heart Interventions

The Best of Intervention From Japan: Advanced PCI Techniques, Imaging and Physiologic Assessment, Endovascular Intervention, and Structural Heart Intervention

The Best of Intervention From China

The Best of Intervention From Latin America

The Best of Intervention From TCT Russia: At the Crossroads of Adult Structural and Congenital Interventions

The Best of Intervention From the Asia-Pacific and India

The Best of Intervention From the Middle East and Africa

Evening Program

Women in Structural Heart (WISH): Breaking the Glass Ceiling ⁠— An Evening of Complex Cases (Sponsored by CRF; Supported by Abbott, Boston Scientific Corporation, Edwards Lifesciences, and Medtronic)

Satellite Special Session

Collaborators in TAVR: A Medtronic Course in Collaboration With CRF for New-to-TAVR Heart Teams

TAVR Foundations for Fellows (Sponsored by Edwards Lifesciences)

Translational Pathways for Cardiovascular Devices (Sponsored by ISCTR)

Oral Abstract Session

AMI and Vulnerable Plaque and Patient Studies

Complications of TAVR and Other Large Devices

DES and Bioresorbable Scaffolds

Endovascular Interventions

Intravascular Imaging

PCI in Patients With Heavily Calcified Lesions and Chronic Kidney Disease

TAVR Complications and Congenital Heart Disease Interventions

CTO Interventions

Complex PCI and Left Main Interventions

Hypertension and Heart Failure Therapies

LAA Closure and Pulmonary Emboli Therapies

Mitral and Tricuspid Valve Interventions

Novel TAVR Data

Physiologic Guidance: Hyperemic, Basal, and Angiographic Studies

Thursday, September 26, 2019

Main Arena

Main Arena I: Thursday, Sept. 26

Live Case Theater

Live Case Transmission Theater I: Thursday, Sept. 26

Live Case Transmission Theater II: Thursday, Sept. 26

Concurrent Session

Metallic DES Part 1: Stent Differences and DAPT Duration

MitraClip Studies and Technique

Large-Bore Access and Closure

PCI Pharmacotherapy: Part 1

Intravascular Imaging Stent Guidance: Part 1 — The Basics

Left Atrial Appendage Closure: Part 1 — LAA Closure: Current Status and Future Directions

TAVR Indications and Complications

The Left Main and Bifurcation Summit: Part 1

Physiologic Lesion Assessment and Interventional Planning: Part 1 — Current Controversies in Coronary Physiology

Pulmonary Hypertension and Acute and Chronic Pulmonary Emboli Therapies: Part 1

STEMI, Cardiac Arrest, and Cardiogenic Shock: Part 1

Innovation Keynote Theater

TCT Innovation III: TCT Shark Tank Innovation Competition

TCT Innovation IV: Global Perspectives in MedTech Innovation II and Digital Healthcare

FDA Town Hall

FDA Town Hall Meeting Part 1: Goals for 2019/2020

Special Session

The Structural Heart Disease Imaging Symposium: A Joint Session With the American Society of Echocardiography

Belt and Road Initiative at TCT 2019: Approach to High-Risk PCI (Experiences From China)

Harmonization by Doing: New Horizons in Japan-US Synergies

SCAI ELM

Japan Endovascular Treatment (JET) @ TCT

OCT Guiding in In-Stent Restenosis (ISR), Presented by the Nordic-Baltic-British Study Group for Interventional Cardiology

International Complex Case Session

International Complex Case Session I: Featured Structural Heart Disease Cases

International Complex Case Session II: Featured Complex Coronary Cases

International Complex Case Session III: Featured Structural Heart Disease Cases

Breakfast Program

Controversies in SFA Intervention (Sponsored by CRF; Supported by Medtronic and WL Gore & Associates)

Innovative Approaches to PCI: Tools to Support Your Patient Care (Sponsored by ACIST Medical Systems)

Intraaortic Balloon Counterpulsation for Percutaneous Aortic Valve or Complex PCI Procedures: Award-Winning Case Presentations (Organized by CRF; Sponsored by Getinge Group)

Keeping the Rhythm With the Tempo® Lead: Safety, Stability, and Cost-Effectiveness for TAVR and Other Cardiac Procedures (Sponsored by BioTrace Medical)

New Perspectives on the Treatment of Functional MR in Patients With Heart Failure (Sponsored by Cardiac Dimensions)

NobleStitch PFO Closure: Recorded Case and Didactic Session (Sponsored by HeartStitch, Inc. and Inova Heart and Vascular Institute)

SuperSaturated Oxygen in STEMI to Reduce Infarct Size: A New FDA-Approved Therapy (Sponsored by TherOx, Inc.)

Treating the Complex Patient: Impella-Enabled Complete Revascularization (Organized by CRF; Sponsored by ABIOMED, Inc.)

Virtue® Sirolimus-Eluting Balloon: Potential Breakthrough Treatment for Coronary ISR (Sponsored by Orchestra BioMed and Terumo Interventional Systems)

Presentation Theater

Onyx One: Data, Details, and Relevance to Your Clinical Practice (Sponsored by Medtronic)

Simplifying Complex PCI Guided by a Second-Generation Fiber-Optic Physiology Guidewire (Sponsored by Opsens Medical)

Transcatheter Tricuspid Valve Interventions (Sponsored by CRF; Supported by Edwards Lifesciences)

A Paradigm Shift in Treating AS: What Is Acceptable Today Will Be Challenged Tomorrow (Sponsored by CRF; Supported by Edwards Lifesciences)

Compelling Cases With Orsiro: Delivering Evidence (Sponsored by BIOTRONIK AG)

Tailoring Transcatheter Mitral Solutions for Patients with Mitral Regurgitation (Sponsored by Abbott)

Transforming DCB Strategy: Sirolimus-Coated Balloon With Nanolute Technology (Sponsored by Concept Medical, Inc.)

Evening Program

Advanced Diagnostic Insight, Precise Patient Care (Sponsored by HeartFlow, Inc.)

TWILIGHT at Twilight: Assessing the Role of Monotherapy vs. Dual Therapy ⁠— Examining Current Data (Sponsored by CRF; Supported by AstraZeneca)

The Team Approach to Cardiac Arrest (Sponsored by TandemLife and LivaNova)

Challenging Case

Challenging Cases 1

Challenging Cases 2

Poster Abstract Session

Poster Abstracts I

Moderated Poster

Assessment of Patients With Aortic Stenosis or Aortic Insufficiency - 1

Intravascular Imaging - 1

Natural History and Management of Mitral and Tricuspid Valve Disease - 1

Outcomes After Primary PCI - 1

Revascularization in Patients With Diabetes - 1

Revascularization in the Elderly and the Frail - 1

Stroke and Stroke Prevention

Vascular Access and Closure in PCI - 1

Bioresorbable Scaffolds - 1

Drug-Eluting Stent Studies - 1

EXCEL Trial Clinical Substudies - 1

Imaging-Derived Physiologic Lesion Assessment - 1

Large-Bore Vascular Access and Closure

Natural History and Management of Mitral and Tricuspid Valve Disease - 2

Outcomes After Primary PCI - 2

Pacemakers and Conduction Abnormalities in Patients With TAVR - 1

Bioresorbable Scaffolds - 2

EXCEL Trial Clinical Substudies - 2

Natural History and Management of Mitral and Tricuspid Valve Disease - 3

Outcomes After Primary PCI - 3

Pacemakers and Conduction Abnormalities in Patients With TAVR - 2

Physiologic Lesion Assessment - 1

Revascularization in the Elderly and the Frail - 2

TAVR and Coronary Artery Disease - 1

Outcomes after Primary PCI - 4

Pacemakers and Conduction Abnormalities in Patients With TAVR - 3

Renal Insufficiency and Contrast Nephropathy - 1

Stent Thrombosis and Restenosis - 1

Assessment of Patients With Aortic Stenosis or Aortic Insufficiency - 2

Drug-Eluting Balloons and Local Drug Delivery - 1

Drug-Eluting Stent Studies - 2

Management of Antiplatelet Therapy and Anticoagulation in Patients Undergoing PCI - 1

Natural History and Management of Mitral and Tricuspid Valve Disease - 4

Physiologic Lesion Assessment - 2

Renal Insufficiency and Contrast Nephropathy - 2

TAVR and Coronary Artery Disease - 2

Drug-Eluting Balloons and Local Drug Delivery - 2

Intravascular Imaging - 2

Management of Antiplatelet Therapy and Anticoagulation in Patients Undergoing PCI - 2

Natural History and Management of Mitral and Tricuspid Valve Disease - 5

Non-Atherosclerotic CAD (SCAD, MINOCA, etc.) - 1

Peripheral Vascular Intervention - 1

Ventricular Assist and Management of Cardiogenic Shock - 1

Drug-Eluting Balloons and Local Drug Delivery - 3

Non-Atherosclerotic CAD (SCAD, MINOCA, etc.) - 2

PCI vs. Medical Therapy and Insights Into Trial Design

Pulmonary Artery and Pulmonary Venous Intervention

TAVR: Patient-Prosthesis Mismatch

TAVR: Valve-in-Valve - 1

Ventricular Assist and Management of Cardiogenic Shock - 2

Vulnerable Plaques and High Risk Patients - 1

Friday, September 27, 2019

Main Arena

Main Arena II: Friday, Sept. 27

Live Case Theater

Live Case Transmission Theater III: Friday, Sept. 27

Live Case Transmission Theater IV: Friday, Sept. 27

Concurrent Session

Metallic DES Part 2: High-Risk Patients and Revascularization Failures

PFO Closure: Evidence, Indications, and Devices

Intravascular Imaging Stent Guidance: Part 2 — The Details

TAVR Technology and Associated Devices

Left Atrial Appendage Closure: Part 2 — Unanswered Questions, Future Directions

PCI Pharmacotherapy: Part 2

TAVR Special Situations (VIV, Bicuspid, AR, Low-Flow, Other)

The Left Main and Bifurcation Summit: Part 2

Physiologic Lesion Assessment and Interventional Planning: Part 2 — New Developments in Coronary Physiology

Pulmonary Hypertension and Acute and Chronic Pulmonary Emboli Therapies: Part 2

STEMI, Cardiac Arrest, and Cardiogenic Shock: Part 2

Transcatheter Mitral Valve Repair: Beyond the MitraClip

Innovation Keynote Theater

TCT Innovation V: Keynote Innovation Interventional Studies

High-Impact Clinical Research I: Peripheral Arterial Disease and Drug-Coated Balloons

High-Impact Clinical Research II: High-Risk Disease and Novel Therapies

High-Impact Clinical Research III: Pharmacotherapy Strategies and Calcified Lesions

FDA Town Hall

FDA Town Hall Meeting Part 2: Hot Topics

Hot Topic Lunch

Cath Lab Radiation Management: In Remembrance of Charles Chambers

Clinical Trial Design, Statistics, and Literature Interpretation: The Evidence-Based Medicine Expert ⁠— Part 1

Detection and Treatment of Vulnerable Plaques and Vulnerable Patients: Are We There Yet?

Diabetic Debates: Revascularization and Medical Therapies

TCT Endovascular: Treatment of Acute Pulmonary Embolism

TCT Endovascular and VEITH: Aortic Therapies

Techniques and Case Studies in PFO Closure

Transcatheter Cardiovascular Innovations in the Underserved: Current Challenges and Opportunities ⁠— Sponsored by the Association of Black Cardiologists

Special Session

Endovascular Cardiac Complications (ECC) 2019: Prevention Is the Best Treatment for Complications

TCT India Session

International Fellows Challenging Case Session

International Complex Case Session

International Complex Case Session IV: Coronary Thrombus Management and Other Special PCI Situations

International Complex Case Session V: Featured Complex Coronary Cases

International Complex Case Session VI: Featured Complex Coronary Cases

Breakfast Program

Alcohol-Mediated Renal Denervation: The Target BP Clinical Program (Sponsored by Ablative Solutions, Inc.)

Expert Experience With Stent Grafts in Treating Challenging Peripheral Disease (Sponsored by WL Gore & Associates)

FFRangio and the Rise of Image-Based Fractional Flow Reserve (FFR) (Sponsored by CathWorks)

Left Main Bifurcation Symposium (Sponsored by India Medtronic Pvt. Ltd.)

Management of Complex PCI Patients: Award-Winning Case Presentations (Organized by CRF; Sponsored by Abiomed, Inc.)

New Frontiers in PCI: Ultra-Low Contrast, Artificial Intelligence, and Co-Registration (Sponsored by Philips)

Optimization of Vessel Access and Closure in Large-Bore Catheter Procedures: Tips and Tricks Case-Based Review (Sponsored by CRF; Supported by Abbott and Saranas)

The Approach to the High Bleeding Risk Patient (Sponsored by CRF; Supported by Abbott, Boston Scientific Corporation, and OrbusNeich)

Transforming Robotics Into an Advanced Clinical Tool Through Automation and Remote Capabilities (Sponsored by Corindus Vascular Robotics)

Presentation Theater

Be Calculated: Case-Based Discussion of Optimizing PCI in Severe Calcific Coronary Artery Disease (Sponsored by Cardiovascular Systems, Inc.)

Contrast-Induced Acute Kidney Injury: Preventive Measures That Work in High-Risk Patients (Sponsored by CRF; Supported by Multiple Commercial Supporters)

State-of-the-Art BP-DES: Optimizing Antiplatelet Therapy After PCI in Complex and High Bleeding Risk Patients (Sponsored by Boston Scientific Corporation)

Transcatheter Mitral Valve Interventions (Sponsored by CRF; Supported by Edwards Lifesciences)

ACURATE neo, LOTUS Edge, and Sentinel CPS: Advancing Safety for TAVR Patients (Sponsored by Boston Scientific Corporation)

The Future of Renal Denervation Is SOUND (Sponsored by ReCor Medical, Inc.)

The Modern Era of Valve Therapy (Sponsored by CRF; Supported by Abbott)

TopShock 2019: The Most Challenging Cases Simplified With IVL (Sponsored by Shockwave Medical)

Evening Program

CHIP Angiogram Review: What’s New? (With Focused Case Presentations) (Sponsored by CRF; Supported by Abbott, ABIOMED, Inc., Boston Scientific Corporation, and CSI)

China: Innovations in Structural Heart Disease (Organized by CRF; Sponsored by Venus Medtech)

Expanding Applications for Intravenous Platelet Inhibition (Sponsored by CRF; Supported by Chiesi)

Challenging Case

Challenging Cases 3

Challenging Cases 4

Poster Abstract Session

Posters Abstracts II

Moderated Poster

LMCA Intervention - 1

Left Atrial Appendage Exclusion - 1

Management of Antiplatelet Therapy and Anticoagulation in Patients Undergoing PCI - 3

Natural History and Management of Bicuspid Aortic Valve Disease

Outcomes After Primary PCI - 5

Peripheral Vascular Intervention - 2

Physiologic Lesion Assessment - 3

Revascularization in Patients With Diabetes - 2

Bioresorbable Scaffolds - 3

Chronic Total Occlusions - 1

Drug-Eluting Stent Studies - 3

LMCA Intervention - 2

Left Atrial Appendage Exclusion - 2

Natural History and Management of Mitral and Tricuspid Valve Disease - 6

Outcomes After Primary PCI - 6

Peripheral Vascular Intervention - 3

Alcohol Septal Ablation/HOCM

Cath Lab of the Future - 1

Chronic Total Occlusions - 2

Rotational and Orbital Atherectomy, Cutting/Scoring Balloons, and Lithotripsy

TAVR: Clinical Access and Cost-Effectiveness - 1

TAVR: Valve-in-Valve - 2

Treatment of Congenital Heart Diseases - 1

Vascular Access and Closure in PCI - 2

Assessment of Patients With Aortic Stenosis or Aortic Insufficiency - 3

Bioresorbable Scaffolds - Metallic

Chronic Total Occlusions - 3

Coronary Bifurcation Intervention

Imaging-Derived Physiologic Lesion Assessment - 2

SVG Intervention

TAVR: Clinical Access and Cost-Effectiveness - 2

TAVR vs. SAVR and TAVR vs. TAVR - 1

Atrial Fibrillation in Patients Undergoing Catheter-Based Intervention

Intravascular Imaging - 3

Out-of-Hospital Arrest

Peripheral Vascular Intervention - 4

Resting Physiologic Indices

TAVR Comorbidities and Complications - 1

Treatment of Congenital Heart Diseases - 2

Vascular Access for TAVR - 1

Cath Lab of the Future - 2

Coronary Perforation and Cardiac Tamponade

Interventional Heart Failure

Stent Thrombosis and Restenosis - 2

Vascular Access for TAVR - 2

Ventricular Assist and Management of Cardiogenic Shock - 3

Saturday, September 28, 2019

Main Arena

Main Arena III: Saturday, Sept. 28

Live Case Theater

Live Case Transmission Theater V: Saturday, Sept. 28

Live Case Transmission Theater VI: Saturday, Sept. 28

Concurrent Session

Hypertension Therapies: Renal Denervation and Beyond

Treatment of Coronary Calcification

Tricuspid Regurgitation: Evolving Concepts and Technologies

The CTO Summit: Part 1

Coronary Drug-Coated Balloons and Bioresorbable Scaffolds

Interventional Heart Failure and Hemodynamic Support: Chronic Therapies

The CTO Summit: Part 2

Transcatheter Mitral Valve Replacement

Mitral Trial Design, Anticoagulation, Imaging, and More

Radial and Femoral Access and Intervention

Innovation Keynote Theater

High-Impact Clinical Research IV: Adjunctive Pharmacotherapy Studies

High-Impact Clinical Research V: Transcatheter Aortic Valve Replacement

High-Impact Clinical Research VI: Management of Cardiogenic Shock

Fascinating Lectures

High-Impact Clinical Research VII: PCI With Physiologic Guidance

High-Impact Clinical Research VIII: Valve Therapies and Non-Cardiac Surgery

High-Impact Clinical Research IX: CAD Diagnosis and Complex PCI Strategies

FDA Town Hall

FDA University at TCT

Hot Topic Lunch

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Center Expertise and Illustrative Case Demonstrations

Chronic Kidney Disease: Preventing and Treating Contrast Nephropathy

Clinical Trial Design, Statistics, and Literature Interpretation: The Evidence-Based Medicine Expert ⁠— Part 2

Combined Structural Interventions: Two Valves, Valve and LAAO, and More

Complex Adult Congenital Intervention

Hypertrophic Cardiomyopathy and Septal Ablation

Spontaneous Coronary Artery Dissection: Novel Insights on Diagnosis and Treatment

TCT Endovascular: Neuro Interventions for Stroke and Carotid Stenosis

Special Session

Challenges and Developments in TAVI Procedure: Argentinean and French Experiences — Presented by Groupe Atherome et Cardiologie Interventionnelle (GACI) and Colegio Argentino de Cardioangiólogos Intervencionistas (CACI)

CSI-NIC India Session @ TCT

International Complex Case Session

International Complex Case Session VII: Featured CHIP and Other Special PCI Situations

International Complex Case Session VIII: A Potpourri of Complex Interventional Cases I

International Complex Case Session IX: A Potpurri of Complex Interventional Cases II

Breakfast Program

Aspirin for the Interventionalist: More Than Meets the Eye (Sponsored by CRF; Supported by PLX Pharma)

Clinical Challenges in High-Risk PCI: A Case-Based Review (Sponsored by CRF Supported by Amgen Inc.)

Coronary Drug-Coated Balloons: Current Challenges, Emerging Clinical Indications, and Future Directions (Sponsored by CRF Supported by B. Braun Interventional Systems and Terumo Interventional Systems)

Current Perspectives and Future Technologies in Below-the-Knee Intervention (Sponsored by CRF; Supported by Medtronic and WL Gore & Associates)

Interventional Therapies for Hypertension: Current Evidence and Controversies (Sponsored by CRF Supported by Ablative Solutions, Orchestra BioMed, and ReCor Medical, Inc.)

Kill Many Birds With One Stone (Sponsored by India Medtronic Pvt. Ltd.)

Next-Generation DES Technology: The Future Is Here! (Sponsored by CRF; Supported by Abbott and Boston Scientific Corporation)

Percutaneous Mitral Interventions: Standard of Care and Future Development (Sponsored by CRF; Supported by Abbott)

Presentation Theater

Future and Scope of Sirolimus-Coated Balloon in Peripheral Vascular Treatment (Sponsored by Concept Medical, Inc.)

New Advances in Physiology and Imaging to Optimize Outcomes (Sponsored by Boston Scientific Corporation)

Standing at the Crossroads of Patient Risk Management: The Role of the Interventional Cardiologist in Lipid Management (Organized by CRF; Sponsored by The Medicines Company)

The Modernized PCI Approach: Why Automatic OCT-Guided Expansion Detection Matters and How to Optimize Outcomes (Sponsored by Abbott)

Ability to Treat Diabetic Patients: With a Novel Combined DES and DCB in a Single Platform (Sponsored by Concept Medical, Inc.)

Novel Technologies From Meril's Armamentarium (Sponsored by Meril Life Sciences Pvt. Ltd.)

Optimizing Management of Patients Undergoing Revascularization (Sponsored by Amgen, Inc.)

The Great Crossings: CHIP Masterclass (Sponsored by Boston Scientific India Pvt. Ltd.)

Evening Program

DAPT and Triple Therapy: A Case-Based Guide to Optimal Antiplatelet Therapies (Sponsored by CRF; Supported by Abbott, Boston Scientific Corporation, and Medtronic)

Oral Abstract Session

Highest Graded Abstracts of TCT 2019

Challenging Case

Challenging Cases 5

Challenging Cases 6

Moderated Poster

Bioresorbable Scaffolds - 4

Drug-Eluting Stent Studies - 4

Hemodynamic Support During PCI

Intravascular Imaging - 4

Novel Aortic Devices and Approaches

Pre-Clinical Models and Studies

Renal Denervation

Vulnerable Plaques and High-Risk Patients - 2

Detection and Closure of Paravalvular Leaks

Drug-Eluting Stent Studies - Biodegradable Polymers

Management of Antiplatelet Therapy and Anticoagulation in Patients Undergoing PCI - 4

PCI and Bleeding Complications

TAVR Comorbidities and Complications - 2

TAVR vs. SAVR and TAVR vs. TAVR - 2

Vascular Access and Closure in PCI - 3

Vulnerable Plaques and High Risk Patients - 3

Age and Gender and Primary PCI

Biomarkers and Outcomes

Cath Lab of the Future - 3

Coronary Artery Surgery

Mortality After PCI

TAVR Comorbidities and Complications - 3

TAVR vs. SAVR and TAVR vs. TAVR - 3

Vascular Access and Closure in PCI - 4

Chronic Total Occlusions - 4

TAVR Comorbidities and Complications - 4

TAVR Leaflet Thickening and Thrombosis

Sunday, September 29, 2019

Main Arena

Main Arena IV: Sunday, Sept. 29

Breakfast Program

Guidewire Design and Selection: A User’s Guide (Sponsored by CRF; Supported by Abbott and Boston Scientific Corporation)

Select a day above, and then the session list will appear on the left. Click or tap a session within that list to view agenda details.